Global venture capital (VC) funding for digital health companies in the first half of 2019 was slightly higher year-over-year, with $5.1 billion raised in 318 deals, compared to the $4.9 billion in 383 deals in the first half of 2018.
Q2 2019 VC funding held strong at $3.1 billion in 169 deals following the $2 billion raised in 149 deals in Q1 2019. This is the highest amount raised in the first six months of a year so far, according to a new report from Mercom Capital Group.
Digital health companies have now received over $40 billion in VC funding deals since 2010, and U.S. digital health companies have raised approximately $30 billion to date. And, total corporate funding in digital health companies—including VC, debt, and public market financing—set a new record for the second quarter with $3.3 billion in Q2 2019 compared to $2.2 billion in Q1 2019. In 1H 2019, there was one IPO for $179.4 million, according to the analysis.
Meanwhile, the top funded categories in 1H 2019 were: analytics with $1.1 billion; telemedicine with $896 million; mHealth apps with $627 million; wellness with $341 million; healthcare booking with $336 million; clinical decision support with $287; and wearable sensors with $285 million.
What’s more, there were 73 early stage deals in Q2 2019, compared to 48 deals in Q1 2019. A total of 821 investors participated in digital health funding deals in the first half of 2019, and there were 450 investors that participated in funding deals in Q2 2019, compared to 371 investors in Q1 2019.
In 1H 2019, there were a total of 91 digital health M&A transactions, compared to 116 in 1H 2018. In Q2 2019, there were 46 M&A transactions, compared to 68 M&A transactions in Q2 2018, the analysis revealed.
In sum, 624 companies and investors were covered in this Mercom Capital Group report.
